NUGLIZIN
Welcome to the Brand page for “NUGLIZIN”, which is offered here for Contraceptive preparations; hormone replacement therapy preparations; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing pharmaceutical preparations; pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; pharmaceuticals and medicines for the treatment and prevention of disorders of the urogenital organs; pharmaceuticals and medicines for the treatment and prevention of disorders of the circulatory systems; pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; all the foregoing pharmaceuticals for human use;.
Its status is currently believed to be active. Its class is unavailable. “NUGLIZIN” is believed to be currently owned by “Teva Pharmaceuticals USA, Inc.”
| Owner: |
TEVA PHARMACEUTICALS USA, INC.
Owner Details |
|---|---|
| Description: |
Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; Pharmaceuticals and medicines for the treatment and prevention of disorders of the urogenital organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; all the foregoing pharmaceuticals for human use;
|
| Categories: | CONTRACEPTIVE PREPARATIONS |
